We are live on ! Find out more
Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT) Portfolio holdings

AUM $89.9B
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
-6.27%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
AUM
$16.8B
AUM Growth
+$3.24B
Cap. Flow
+$4.87B
Cap. Flow %
28.99%
Top 10 Hldgs %
10.37%
Holding
3,295
New
862
Increased
762
Reduced
768
Closed
837

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$169M
2
KO icon
Coca-Cola
KO
+$155M
3
MCD icon
McDonald's
MCD
+$140M
4
MDLZ icon
Mondelez International
MDLZ
+$127M
5
DRE
Duke Realty Corp.
DRE
+$120M

Sector Composition

Rank Sector Weight
1 Technology 20.63%
2 Financials 11.8%
3 Healthcare 10.7%
4 Industrials 9.22%
5 Consumer Discretionary 8.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SMMT icon
2301
Summit Therapeutics
SMMT
$10B
$20K ﹤0.01%
17,120
-1,691
-9% -$1.91K
TECX
2302
Tectonic Therapeutic
TECX
$562M
$20K ﹤0.01%
2,577
-357
-12% -$3.96K
TRVN
2303
DELISTED
Trevena, Inc.
TRVN
$20K ﹤0.01%
210
-31
-13% -$4.75K
MTEM
2304
DELISTED
Molecular Templates, Inc.
MTEM
$20K ﹤0.01%
1,738
-228
-12% -$2.87K
IDLV icon
2305
Invesco S&P International Developed Low Volatility ETF
IDLV
$344M
$19K ﹤0.01%
+757
New +$20.8K
SYRE icon
2306
Spyre Therapeutics
SYRE
$8.68B
$19K ﹤0.01%
1,459
-179
-11% -$2.21K
ATNX
2307
DELISTED
Athenex, Inc. Common Stock
ATNX
$19K ﹤0.01%
3,532
-261
-7% -$2.68K
ALGS icon
2308
Aligos Therapeutics
ALGS
$26.3M
$18K ﹤0.01%
641
-107
-14% -$3.55K
BIB icon
2309
ProShares Ultra NASDAQ Biotechnology
BIB
$84.4M
$18K ﹤0.01%
383
+129
+51% +$6.88K
FAN icon
2310
First Trust Global Wind Energy ETF
FAN
$272M
$18K ﹤0.01%
1,208
-108
-8% -$1.91K
QNCX icon
2311
Quince Therapeutics
QNCX
$18.9M
$18K ﹤0.01%
68
-53
-44% -$20.2K
RWX icon
2312
State Street SPDR Dow Jones International Real Estate ETF
RWX
$267M
$18K ﹤0.01%
755
-24,723
-97% -$691K
RXL icon
2313
ProShares Ultra Health Care
RXL
$89.3M
$18K ﹤0.01%
460
+388
+539% +$17.1K
SVXY icon
2314
ProShares Short VIX Short-Term Futures ETF
SVXY
$224M
$18K ﹤0.01%
734
-3,822
-84% -$100K
LOTZ
2315
DELISTED
CarLotz, Inc. Class A Common Stock
LOTZ
$18K ﹤0.01%
58,614
-42,427
-42% -$18.5K
BDSX icon
2316
Biodesix
BDSX
$218M
$17K ﹤0.01%
681
-103
-13% -$3.97K
EMHY icon
2317
iShares JPMorgan EM High Yield Bond ETF
EMHY
$620M
$17K ﹤0.01%
524
-875
-63% -$30.1K
HEZU icon
2318
iShares Currency Hedged MSCI Eurozone ETF
HEZU
$567M
$17K ﹤0.01%
+573
New +$18K
HIBL icon
2319
Direxion Daily S&P 500 High Beta Bull 3X ETF
HIBL
$74.7M
$17K ﹤0.01%
+816
New +$25.8K
HOOK
2320
DELISTED
HOOKIPA Pharma
HOOK
$17K ﹤0.01%
1,270
-149
-11% -$2.29K
UWM icon
2321
ProShares Ultra Russell2000
UWM
$249M
$17K ﹤0.01%
580
-2,789
-83% -$98.8K
XITK icon
2322
State Street SPDR FactSet Innovative Technology ETF
XITK
$67.5M
$17K ﹤0.01%
+166
New +$18.7K
RUBY
2323
DELISTED
Rubius Therapeutics, Inc
RUBY
$17K ﹤0.01%
38,225
-846
-2% -$634
FM
2324
DELISTED
iShares Frontier and Select EM ETF
FM
$17K ﹤0.01%
680
-682
-50% -$18.4K
DFJ icon
2325
WisdomTree Japan SmallCap Dividend Fund
DFJ
$380M
$16K ﹤0.01%
288
+135
+88% +$8.11K

Similar funds

Qube Research & Technologies (QRT)'s Q3 2022 Portfolio in Review

As of Q3 2022, Qube Research & Technologies (QRT) held 3,295 positions worth $16.8B, up 24% from $13.6B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Qube Research & Technologies (QRT) deployed $4.87B of net new capital in Q3 2022, opening 862 new positions and adding to 762 existing holdings. Its largest new stake was Coca-Cola: 2,493,071 shares worth $140M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Marathon Petroleum, an estimated $174M trimmed.

  • Qube Research & Technologies (QRT)'s largest Q3 2022 buy was Coca-Cola: 2,493,071 shares worth $140M.
  • Qube Research & Technologies (QRT) added most to Visa in Q3 2022, an estimated $169M increase.
  • Qube Research & Technologies (QRT)'s biggest Q3 2022 reduction was Marathon Petroleum, cutting an estimated $174M.
  • Qube Research & Technologies (QRT) fully exited Phillips 66 in Q3 2022, selling an estimated $86.2M.
  • Qube Research & Technologies (QRT)'s ten largest holdings make up 10% of its $16.8B portfolio in Q3 2022.
  • Qube Research & Technologies (QRT) opened 862 new positions and closed 837 in Q3 2022.
  • Qube Research & Technologies (QRT)'s portfolio value rose 24% quarter-over-quarter to $16.8B.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2022, filed 14 Nov 2022.